Principal Financial Group Lifted By $444,720 Its Nbt Bancorp (NBTB) Stake; Cardiovascular Systems (CSII) Has 1.31 Sentiment

Principal Financial Group Inc increased Nbt Bancorp Inc (NBTB) stake by 3.71% reported in 2018Q4 SEC filing. Principal Financial Group Inc acquired 13,080 shares as Nbt Bancorp Inc (NBTB)’s stock declined 0.70%. The Principal Financial Group Inc holds 365,558 shares with $12.65M value, up from 352,478 last quarter. Nbt Bancorp Inc now has $1.64B valuation. The stock decreased 0.74% or $0.28 during the last trading session, reaching $37.36. About 37,249 shares traded. NBT Bancorp Inc. (NASDAQ:NBTB) has risen 9.23% since May 15, 2018 and is uptrending. It has outperformed by 4.86% the S&P500.

Cardiovascular Systems Inc (CSII) investors sentiment increased to 1.31 in Q4 2018. It’s up 0.18, from 1.13 in 2018Q3. The ratio increased, as 77 hedge funds opened new or increased holdings, while 59 sold and decreased their stock positions in Cardiovascular Systems Inc. The hedge funds in our database reported: 28.47 million shares, up from 27.24 million shares in 2018Q3. Also, the number of hedge funds holding Cardiovascular Systems Inc in top ten holdings was flat from 1 to 1 for the same number . Sold All: 19 Reduced: 40 Increased: 55 New Position: 22.

Cardiovascular Systems, Inc., a medical technology company, develops, makes, and markets devices to treat vascular diseases in the United States. The company has market cap of $1.34 billion. The firm offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System , Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It has a 653.22 P/E ratio. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries.

More notable recent Cardiovascular Systems, Inc. (NASDAQ:CSII) news were published by: Nasdaq.com which released: “Cardiovascular Systems (CSII) Q3 Earnings Top, View Tapered – Nasdaq” on May 02, 2019, also Nasdaq.com with their article: “Analysts Estimate Cardiovascular Systems (CSII) to Report a Decline in Earnings: What to Look Out for – Nasdaq” published on April 24, 2019, Nasdaq.com published: “Here’s Why You Should Hold on to PerkinElmer (PKI) Stock Now – Nasdaq” on May 14, 2019. More interesting news about Cardiovascular Systems, Inc. (NASDAQ:CSII) were released by: Finance.Yahoo.com and their article: “Here’s What Hedge Funds Think About Orthofix Medical Inc. (OFIX) – Yahoo Finance” published on May 03, 2019 as well as Finance.Yahoo.com‘s news article titled: “Hedge Funds Have Never Been This Bullish On Sonos, Inc. (SONO) – Yahoo Finance” with publication date: May 03, 2019.

The stock increased 1.05% or $0.4 during the last trading session, reaching $38.54. About 197,503 shares traded. Cardiovascular Systems, Inc. (CSII) has risen 69.79% since May 15, 2018 and is uptrending. It has outperformed by 65.42% the S&P500. Some Historical CSII News: 15/03/2018 – ClinicalTrial US: Early Detection of Cardiovascular Disease (VIBE); 07/03/2018 – Global Cardiovascular Drugs Market: Incessantly Rising Cases of Hypertension and Hyperlipidemia to Fuel Market Growth, Says TMR; 04/04/2018 – ClinicalTrial US: Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2); 16/04/2018 – JANSSEN ANNOUNCES WORLDWIDE DEVELOPMENT & COMMERCIALIZATION COLLABORATION WITH BRISTOL-MYERS TO ADVANCE THERAPY FOR CARDIOVASCULAR DISEASES; 23/03/2018 – CSL BEHRING -TRIAL TO EVALUATE EFFICACY, SAFETY OF CSL112 FOR REDUCTION OF EARLY RECURRENT CARDIOVASCULAR EVENTS FOLLOWING ACUTE MYOCARDIAL INFARCTION; 17/04/2018 – ClinicalTrial US: Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk; 23/03/2018 – CSL BEHRING ANNOUNCES FIRST PATIENT ENROLLMENT IN PHASE 3 CLINICAL TRIAL OF CSL112 TO ASSESS REDUCTION OF EARLY RECURRENT CARDIOVASCULAR EVENTS IN HEART ATTACK SURVIVORS; 11/03/2018 – J&J Unit: Invokana Significantly Reduces Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease; 12/03/2018 – Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Cardiovascular Events and Healthcare Co; 09/04/2018 – The American Heart Association’s Innovative Solution Personalizes Cardiovascular Condition Management With Tailored Engagement

First Light Asset Management Llc holds 2.19% of its portfolio in Cardiovascular Systems, Inc. for 482,104 shares. Perkins Capital Management Inc owns 84,150 shares or 1.86% of their US portfolio. Moreover, Ironwood Investment Management Llc has 1.39% invested in the company for 52,681 shares. The New York-based Bridger Management Llc has invested 1.27% in the stock. Brown Capital Management Llc, a Maryland-based fund reported 3.61 million shares.

Analysts await Cardiovascular Systems, Inc. (NASDAQ:CSII) to report earnings on July, 29. They expect $0.04 EPS, down 63.64% or $0.07 from last year’s $0.11 per share. CSII’s profit will be $1.39 million for 240.88 P/E if the $0.04 EPS becomes a reality. After $0.02 actual EPS reported by Cardiovascular Systems, Inc. for the previous quarter, Wall Street now forecasts 100.00% EPS growth.

Investors sentiment increased to 1.38 in Q4 2018. Its up 0.52, from 0.86 in 2018Q3. It is positive, as 9 investors sold NBTB shares while 36 reduced holdings. 20 funds opened positions while 42 raised stakes. 23.80 million shares or 4.48% more from 22.78 million shares in 2018Q3 were reported. Kbc Nv reported 14,851 shares or 0.01% of all its holdings. State Of Tennessee Treasury Department holds 0% or 19,424 shares in its portfolio. Moreover, First has 0.06% invested in NBT Bancorp Inc. (NASDAQ:NBTB) for 14,685 shares. Mason Street Advsr invested in 0.01% or 13,561 shares. Sg Americas Ltd stated it has 0% in NBT Bancorp Inc. (NASDAQ:NBTB). 15,320 were accumulated by Strategic Fincl Svcs. State Of Alaska Department Of Revenue holds 0.01% or 14,583 shares in its portfolio. 565 are owned by Arrow. Nbt Retail Bank N A Ny stated it has 1.04% in NBT Bancorp Inc. (NASDAQ:NBTB). Credit Suisse Ag owns 33,409 shares or 0% of their US portfolio. Walthausen & Communication Ltd Liability Corporation reported 181,600 shares. D E Shaw And holds 0% or 6,171 shares in its portfolio. Baker Ellis Asset Limited Liability Corp owns 10,000 shares. Renaissance Techs Ltd Liability reported 0% of its portfolio in NBT Bancorp Inc. (NASDAQ:NBTB). Wells Fargo And Mn invested in 117,554 shares or 0% of the stock.

Since January 15, 2019, it had 0 buys, and 1 sale for $168,363 activity. Another trade for 4,634 shares valued at $168,363 was made by CHEWENS MICHAEL J on Tuesday, January 15.

Principal Financial Group Inc decreased Newell Brands Inc (NYSE:NWL) stake by 26,957 shares to 626,648 valued at $11.65M in 2018Q4. It also reduced Live Nation Entertainment In (NYSE:LYV) stake by 180,394 shares and now owns 4.68M shares. World Fuel Svcs Corp (NYSE:INT) was reduced too.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.